In the context of breast carcinomas, GATA3 is predominantly expressed in hormone receptor-positive tumors (luminal A and luminal B) and HER2-positive carcinomas [33], while SOX10 serves as a hallmark stain for triple-negative (basal-like) carcinomas [26]. Here, NR4A1 is linked to breast carcinoma.